EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Serum metabolome analysis in hyperthyroid cats before and after radioactive iodine therapy

Molly A Bechtold, Yimei Lin, Meredith L Miller, Jennifer M Prieto, Carol E Frederick, Lucinda L Bennett, Mark E Peterson, Kenneth W Simpson, John P Loftus iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0305271 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Molly A Bechtold und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, United States of America. Hauptthemen laut MEDLINE: Hyperthyroidism, Metabolome, Iodine Radioisotopes, Cat Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cornell Feline Health Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hyperthyroidism is the most common feline endocrinopathy. In hyperthyroid humans, untargeted metabolomic analysis identified persistent metabolic derangements despite achieving a euthyroid state. Therefore, we sought to define the metabolome of hyperthyroid cats and identify ongoing metabolic changes after treatment. We prospectively compared privately-owned hyperthyroid cats (n = 7) admitted for radioactive iodine (I-131) treatment and euthyroid privately-owned control (CON) cats (n = 12). Serum samples were collected before (T0), 1-month (T1), and three months after (T3) I-131 therapy for untargeted metabolomic analysis by MS/MS. Hyperthyroid cats (T0) had a distinct metabolic signature with 277 significantly different metabolites than controls (70 increased, 207 decreased). After treatment, 66 (T1 vs. CON) and 64 (T3 vs. CON) metabolite differences persisted. Clustering and data reduction analysis revealed separate clustering of hyperthyroid (T0) and CON cats with intermediate phenotypes after treatment (T1 & T3). Mevalonate/mevalonolactone and creatine phosphate were candidate biomarkers with excellent discrimination between hyperthyroid and healthy cats. We found several metabolic derangements (e.g., decreased carnitine and α-tocopherol) do not entirely resolve after achieving a euthyroid state after treating hyperthyroid cats with I-131. Further investigation is warranted to determine diagnostic and therapeutic implications for candidate biomarkers and persistent metabolic abnormalities.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyperthyroidismMetabolomeIodine RadioisotopesCat DiseasesAnimalsCatsMaleFemaleBiomarkersMetabolomics

Substanzen

Iodine RadioisotopesBiomarkers

Autor:innen und Institutionen

  • Department of Clinical Sciences, College of Veterinary Medicine, Cornell University, Ithaca, New York, United States of America.
  • Animal Endocrine Clinic, New York, New York, United States of America.

ORCID-Profile: John P Loftus

Förderung

  • Cornell Feline Health Center

Zitieren

APA

Bechtold, M. A., Lin, Y., Miller, M. L., Prieto, J. M., Frederick, C. E., Bennett, L. L., Peterson, M. E., Simpson, K. W., & Loftus, J. P. (2024). Serum metabolome analysis in hyperthyroid cats before and after radioactive iodine therapy. PLOS ONE. https://doi.org/10.1371/journal.pone.0305271

Vancouver

Bechtold MA, Lin Y, Miller ML, Prieto JM, Frederick CE, Bennett LL, et al. Serum metabolome analysis in hyperthyroid cats before and after radioactive iodine therapy. PLOS ONE. 2024. doi:10.1371/journal.pone.0305271

BibTeX
@article{Bechtold2024,
  author = {Bechtold, Molly A and Lin, Yimei and Miller, Meredith L and Prieto, Jennifer M and Frederick, Carol E and Bennett, Lucinda L and Peterson, Mark E and Simpson, Kenneth W and Loftus, John P},
  title = {Serum metabolome analysis in hyperthyroid cats before and after radioactive iodine therapy},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0305271}
}
Kostenlos starten →